All stock lists
Unlock the score
Damora Therapeutics, Inc. (NASDAQ:DMRA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
21.26+0.17 (+0.81%)
Market cap
$1.31B
Insider Score
Health Score
Analyst consensus
Listed since
Oct 29, 2020
Website
Insider Score
/ 100
DMRA Insider Score
Damora Therapeutics, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
DMRA Stock Insider Trading Activity
DMRA stock’s insider trading shows 1 purchase for an estimated $252.88K and 1 sale on the open market for an estimated $7.35K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days1 qualifying buy1 insider$252.88K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Jarrett Jennifer CEO | Buy | 12,500 | $20.23 | $252.88K | 2.5% | 512,500 | Sep 25, 2026 | BFirst BuyCEO BuyDilution | Form 4 |
| Winslow Garrett Other | Sell | 245 | $29.98 | $7.35K | 9.7% | 2,289 | Jul 6, 2026 | — | Form 4 |
| Winslow Garrett Other | Option exercise | 680 | — | — | 36.7% | 2,534 | Jul 3, 2026 | — | Form 4 |
| Jarrett Jennifer Director | Award | 500,000 | — | — | New | 500,000 | Mar 30, 2026 | — | Form 4 |
| Fairmount Funds Management LLC Director | Option exercise | 5,809,000 | — | — | New | 5,809,000 | Feb 9, 2026 | — | Form 4 |
| Fairmount Funds Management LLC Director | Option exercise | 2,904,000 | — | — | New | 2,904,000 | Feb 9, 2026 | — | Form 4 |
| Bruno Julianne Director | Option exercise | 129,000 | — | — | 1606% | 137,032 | Feb 9, 2026 | — | Form 4 |
| Hewes L. Becker Other | Award | 264,629 | — | — | New | 264,629 | Jan 5, 2026 | — | Form 4 |
| Sattarzadeh Sherwin COO | Award | 190,376 | — | — | New | 190,376 | Jan 5, 2026 | — | Form 4 |
| Schambye Hans T. CEO | Sell | 700 | $21.38 | $14.97K | 13.0% | 4,682 | Jan 2, 2026 | — | Form 4 |
| Winslow Garrett Other | Option exercise | 680 | — | — | 47.6% | 2,109 | Jan 2, 2026 | — | Form 4 |
| Winslow Garrett Other | Sell | 255 | $21.38 | $5.45K | 12.1% | 1,854 | Jan 2, 2026 | — | Form 4 |
| Firmani Lori CFO | Option exercise | 374 | — | — | 54.0% | 1,066 | Jan 2, 2026 | — | Form 4 |
| Firmani Lori CFO | Sell | 135 | $21.41 | $2.89K | 12.7% | 931 | Jan 2, 2026 | — | Form 4 |
| Schambye Hans T. CEO | Option exercise | 1,360 | — | — | 33.8% | 5,382 | Jan 2, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Sell (S) — Open-market or private sale
- Award (A) — Grant or award from the company, not a purchase
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.